By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Using an array of technologies, researchers at the University of British Columbia, Cross Cancer Institute of Alberta, and Cancer Research UK have illustrated just how complex triple negative breast cancer tumors are and how their mutational patterns evolve throughout tumor progression.

The finding could help explain why this particular subtype of breast cancer is so good at resisting treatment, and could eventually lead to more effective therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.